Dr. Claire Meaney is a member of the Research, Development and Innovation team at Limerick Institute of Technology and Principal Investigator within the Shannon Applied Biotechnology Centre. She received her B. Eng in Biomedical Engineering from the University of Limerick and was awarded an Irish Research Council scholarship to conduct her doctoral studies under the supervision of Prof. Tim McGloughlin within the Centre of Applied Biomedical Engineering Research in the University of Limerick’s School of Engineering. Her thesis examined the flow induced stress response of arterial cells with naturally derived vascular graft materials.

After successfully completing her Ph.D at the University of Limerick, Claire was awarded a position on the USA’s National Cancer Institute, Cancer Prevention Fellowship Program. This postdoctoral program was co-funded by the Health Research Board and the National Institutes of Health, USA. As part of Claire’s post-doctoral work, she was funded by the Irish Health Research Board to complete a Masters of Public Health at University College Dublin and her dissertation focused on breast cancer survival characteristics in relation to trastuzumab treatment over a ten year period.

Upon completing her M.P.H., Dr. Meaney and spent three and a half years at the US National Cancer Institute in Bethesda, Maryland, conducting research in biomarker development under the mentorship of Dr. Brid Ryan, and 3D models of tumour microenvironments at the Laboratory of Human Carcinogenesis and Division of Cancer Prevention. While completing her post-doctoral work, Dr. Meaney was competitively selected as a recipient of the 2016/2017 National Cancer Institute, Sallie Rosen Kaplan Leadership Award for Women in Science and served as a Technology Transfer Ambassador for the National Cancer Institute’s collaborative technology transfer programme with Johns Hopkins University and local biotech stakeholders. During her time at the NIH, Dr. Meaney managed multiple research projects, teaching activities, leadership and grant writing training programmes, and worked as part of a team in the development and management of extramural grant mechanisms within the National Institutes of Health Small Business Innovation Research (SBIR) Program.

Upon her return to Ireland, Dr Meaney was awarded a reintegration award to from the Irish Cancer Society and Health Research Board to fund her lung cancer research program in Ireland and began working as an independent principal investigator. The focus of Dr. Meaney’s current research is the computational evaluation of morphologic tumour tissue features as diagnostic and prognostic predictors of lung cancer using digital pathology platforms. Dr. Meaney joined the IACR Junior Council in 2019.